Financial News
DateTitlemore >
Jun. 26, 2008New Data Show Preemptive Treatment May Significantly Reduce Skin Toxicities in Patients Receiving Vectibix(R) (Panitumumab)
Jun. 18, 2008Amgen and Wyeth Statement on Outcome of Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) Meeting
Jun. 18, 2008Enbrel(R) (etanercept) Application for the Treatment of Pediatric Psoriasis to be Discussed at FDA Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) Meeting
Jun. 15, 2008Romiplostim Data Show Potential Long-Term Efficacy and Safety in Adults with Chronic ITP
Jun. 9, 2008Amgen SVP of North American Commercial Operations James Daly to Present at the Goldman Sachs Healthcare Conference
Jun. 6, 2008Amgen Names Anna Richo Senior Vice President of Worldwide Compliance
Related Links Stock Quote


AMGN: NASDAQ
$50.84

 (Minimum 20 minute delay)